Your browser doesn't support javascript.
loading
Increased IKKϵ protein stability ensures efficient type I interferon responses in conditions of TBK1 deficiency.
Wegner, Julia; Hunkler, Charlotte; Ciupka, Katrin; Hartmann, Gunther; Schlee, Martin.
Affiliation
  • Wegner J; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Hunkler C; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Ciupka K; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Hartmann G; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Schlee M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
Front Immunol ; 14: 1073608, 2023.
Article in En | MEDLINE | ID: mdl-36936901
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / I-kappa B Kinase Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / I-kappa B Kinase Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Germany